Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial

NCT07576660 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT07576660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07576660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial
Lead sponsor
Southeast University, China
Phase
Phase 3
Overall status
Recruiting
Start date
August 27, 2026
Completion date
September 30, 2030
Enrollment
1,704 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome (ards)